Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000353569-21-000091
Filing Date
2021-11-05
Accepted
2021-11-04 18:09:54
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qdel-20210930.htm   iXBRL 10-Q 1278521
2 EX-31.1 ex31120210930.htm EX-31.1 9790
3 EX-31.2 ex31220210930.htm EX-31.2 9901
4 EX-32.1 ex32120210930.htm EX-32.1 5704
  Complete submission text file 0000353569-21-000091.txt   5671298

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20210930.xsd EX-101.SCH 34228
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20210930_cal.xml EX-101.CAL 66704
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20210930_def.xml EX-101.DEF 147824
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20210930_lab.xml EX-101.LAB 513454
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20210930_pre.xml EX-101.PRE 313159
10 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20210930_htm.xml XML 920925
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-10961 | Film No.: 211381502
SIC: 2835 In Vitro & In Vivo Diagnostic Substances